Open AccessS151: HIGH‐THROUGHPUT EVALUATION OF THE POTENTIAL OF CANCER DRUGS TO ENHANCE NATURAL KILLER CELL IMMUNOTHERAPY IN CHRONIC MYELOID LEUKEMIA.
Author(s) -
Nygren P.,
Bouhlal J.,
Laajala E.,
Ianevski A.,
Klievink J.,
Lähteenmäki H.,
Saeed K.,
Lee D.,
Aittokallio T.,
Dufva O.,
Mustjoki S.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843496.24684.80
Subject(s) - myeloid leukemia , immunotherapy , cancer research , natural killer cell , imatinib , cytotoxicity , cancer , cancer cell , k562 cells , cancer immunotherapy , leukemia , immunology , medicine , pharmacology , biology , in vitro , biochemistry